GLPBio

Immunology/Inflammation

Read More about this category

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Research Areas

Products Related to Immunology/Inflammation(4922)

  • GC81818 structure
    GC8181811β,13-Dihydrolactucopicrin
    CAS: 125519-47-3
    Purity: >98.00%

    11β,13-Dihydrolactucopicrin is a sesquiterpene lactone and the main bitter component of chicory root.

  • GC81825 structure
    GC81825ASO-4625
    Purity: >98.00%

    ASO-4625 is a 20-nucleotide gapmer antisense oligonucleotide with a full phosphorothioate backbone and 2'-O-(2-methoxy) ethyl ribose modifications, which targets BCL2 mRNA and BCL2L1 mRNA.

  • GC81827 structure
    GC81827Buforin IIb TFA
    Purity: >98.00%

    Buforin IIb TFA (BF2-B TFA) is an anticancer peptide, as well as an Antibacterial and Antifungal agent.

  • GC81835 structure
    GC81835G4232
    Purity: >98.00%

    G4232 is an immune-silent BCL2 antisense oligonucleotide that binds to BCL2 mRNA to induce target degradation and inhibit Bcl-2 protein translation.

  • GC81842 structure
    GC81842Lck Inhibitor III free base
    CAS: 918870-44-7
    Purity: >98.00%

    Lck Inhibitor III free base is a Lck inhibitor with an IC 50 of 867 nM.

  • GC81846 structure
    GC81846Nivitol
    CAS: 869743-37-3
    Purity: >98.00%

    Nivitol (UP302) is a natural phenolic compound discovered from Dianella ensifolia and also acts as a Tyrosinase inhibitor.

  • GC81850 structure
    GC81850p53 Bipartite NLS TFA
    Purity: >98.00%

    p53 Bipartite NLS TFA is a bipartite nuclear localization signal derived from p53.

  • GC81862 structure
    GC81862YJ1206 TFA
    Purity: >98.00%

    YJ1206 TFA is an orally active selective CDK12 / CDK13 PROTAC degrader.

  • GC81864 structure
    GC818643BP-3580 TFA
    Purity: >98.00%

    3BP-3580 TFA (compound 11) is a conjugate targeting FAP that binds to FAP-positive cells via the FAPI moiety and internalizes, delivering the payload to FAP -expressing cells, thereby inhibiting RA FLS proliferation, migration, and invasion, reducing inflammatory cytokine expression, and suppressing pannus formation.

  • GC81872 structure
    GC81872CPTH2-d₄
    Purity: >98.00%

    CPTH2 -d 4 is the deuterated-labeled CPTH2.

  • GC81873 structure
    GC81873Ciprofloxacin hydrochloride
    CAS: 86483-48-9
    Purity: >98.00%

    Ciprofloxacin hydrochloride (Bay-09867 hydrochloride) is an orally active, blood-brain barrier permeable fluoroquinolone antibacterial agent.

  • GC81879 structure
    GC81879NCP26 TFA
    Purity: >99.50%

    NCP26 TFA is an ATP-competitive ProRS inhibitor (with a K D of 271 nM in the absence of proline, and a K D of 0.35 nM in the presence of 100 μM proline).

  • GC81880 structure
    GC81880OSU-2S TFA
    Purity: >98.00%

    OSU-2S TFA is a non-immunosuppressive derivative of Fingolimod hydrochloride (FTY720).

  • GC81890 structure
    GC81890Temozolomide-¹⁵N
    Purity: >98.00%

    Temozolomide - 15 N (NSC 362856- 15 N) is the 15 N-labeled Temozolomide.

  • GC81891 structure
    GC81891Tri-GalNAc-NH2
    CAS: 1646198-77-7
    Purity: >98.00%

    Tri-GalNAc-NH2 is a synthetic tri-N-acetylgalactosamine ligand that targets the asialoglycoprotein receptor (ASGPR).

  • GC81898 structure
    GC81898LLC355
    Purity: >99.50%

    LLC355 is a discoidin domain receptor 1 ( DDR1 ) ATTEC degrader with a DC 50 of 150.8 nM.

  • GC90022 structure
    GC90022(±)-Norepinephrine-d6 (hydrochloride)
    CAS: 1219803-04-9
    Purity: >99.00%

    Un standard interne pour la quantification de la norépinéphrine.

  • GC90030 structure
    GC90030Demethoxycurcumin
    CAS: 22608-11-3
    Purity: >98.00%

    Curcuminoïde naturel avec des rôles dans le cancer et l'inflammation.

  • GC90076 structure
    GC90076HA-14-1
    CAS: 927635-64-1
    Purity: >95.00%

    Un inhibiteur de Bcl-2

  • GC90077 structure
    GC90077Furin Inhibitor I (trifluoroacetate salt)
    Purity: >95.00%

    Un inhibiteur de proprotéine convertase

  • GC90195 structure
    GC90195Posaconazole-d5
    CAS: 2649530-57-2
    Purity: >98.00%

    Un standard interne pour la quantification du posaconazole.

  • GC90243 structure
  • GC90363 structure
    GC9036310(11)-Cl-BBQ
    Purity: >95.00%

    Un mélange qui agit comme un agoniste de l'AhR.

  • GC90483 structure
    GC90483Magainin 1 (trifluoroacetate salt)
    Purity: >95.00%

    Un peptide cationique antimicrobien